Detection of minimal residual disease in lung cancer

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F14%3A33150537" target="_blank" >RIV/61989592:15110/14:33150537 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00098892:_____/14:#0000751

Výsledek na webu

<a href="http://biomed.papers.upol.cz/artkey/bio-201402-0005_Detection_of_minimal_residual_disease_in_lung_cancer.php?back=%2Fsearch.php%3Fquery%3DChudacek%26sfrom%3D0%26spage%3D30" target="_blank" >http://biomed.papers.upol.cz/artkey/bio-201402-0005_Detection_of_minimal_residual_disease_in_lung_cancer.php?back=%2Fsearch.php%3Fquery%3DChudacek%26sfrom%3D0%26spage%3D30</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5507/bp.2013.019" target="_blank" >10.5507/bp.2013.019</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Detection of minimal residual disease in lung cancer

Popis výsledku v původním jazyce

Background. Even after successful radical treatment of lung cancer, patients in stages I and II frequently suffer recurrence, which end lethally. Detection of subclinical residual disease after surgery is thus one of the most important emerging diagnostic methods. Minimal residual disease (MRD) is defined as the presence of isolated tumor cells or circulating cells in a patient after curative primary tumor removal and at the same time, no clinical signs of cancer. Conventional methods cannot detect MRDand hence there is a need for new molecular biological methods. Methods. We searched the PubMed database for original and review articles on MRD in lung cancer. Search words were "lung cancer", "minimal residual disease" and "detection of minimal residual disease". The publications we found were compared with the results of our own studies on the detection of MRD in lung cancer and the personal experiences are described. Examination of blood samples from 98 healthy volunteers and bone ma

Název v anglickém jazyce

Detection of minimal residual disease in lung cancer

Popis výsledku anglicky

Background. Even after successful radical treatment of lung cancer, patients in stages I and II frequently suffer recurrence, which end lethally. Detection of subclinical residual disease after surgery is thus one of the most important emerging diagnostic methods. Minimal residual disease (MRD) is defined as the presence of isolated tumor cells or circulating cells in a patient after curative primary tumor removal and at the same time, no clinical signs of cancer. Conventional methods cannot detect MRDand hence there is a need for new molecular biological methods. Methods. We searched the PubMed database for original and review articles on MRD in lung cancer. Search words were "lung cancer", "minimal residual disease" and "detection of minimal residual disease". The publications we found were compared with the results of our own studies on the detection of MRD in lung cancer and the personal experiences are described. Examination of blood samples from 98 healthy volunteers and bone ma

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FJ - Chirurgie včetně transplantologie

OECD FORD obor

—

Projekt

<a href="/cs/project/NT14406" target="_blank" >NT14406: Monitorování efektu léčby karcinomu plic pomocí kvantitativní analýzy genové exprese biomarkerů minimální zbytkové nemoci</a><br>

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Biomedical Papers-Olomouc

ISSN

1213-8118

e-ISSN

—

Svazek periodika

158

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

189-193

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—